Log in

Relevant bibliographies by topics / Polyquad / Journal articles

To see the other types of publications on this topic, follow the link: Polyquad.

Journal articles on the topic 'Polyquad'

Author: Grafiati

Published: 7 June 2025

Last updated: 17 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 40 journal articles for your research on the topic 'Polyquad.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Good, Ralph M., John C. Liao, Joan M. Hook, and Cathy L. Punko. "Colorimetric Determination of a Polymeric Quaternary Ammonium Antimicrobial Preservative in an Ophthalmic Solution." Journal of AOAC INTERNATIONAL 70, no. 6 (1987): 979–80. http://dx.doi.org/10.1093/jaoac/70.6.979.

Full text

Abstract:

Abstract A simple colorimetric method is presented for the determination of Polyquad®, a polymeric quaternary ammonium antimicrobial preservative, in an ophthalmic solution. Polyquad and magnesium are coprecipitated by ion pairing with Ponceau S, a highly colored sulfonate dye, at an acidic pH. The sample is centrifuged and the supernate analyzed spectrophotometrically. The concentration of Polyquad is determined by the decrease in dye concentration. Formulation excipients such as disodium edetate, dextran, and hydroxypropylraethylcellulose did not interfere with the quantitation. The method i

APA, Harvard, Vancouver, ISO, and other styles

2

Campolo, Allison, Brian Patterson, Esther Lara, Paul Shannon, and Monica Crary. "Complete Recovery of Acanthamoeba Motility among Surviving Organisms after Contact Lens Care Disinfection." Microorganisms 11, no. 2 (2023): 299. http://dx.doi.org/10.3390/microorganisms11020299.

Full text

Abstract:

Acanthamoeba keratitis is a sight-threatening infection of the cornea which is extremely challenging to treat. Understanding this organism’s responses during contact lens contact and disinfection could enhance our understanding of how Acanthamoebae colonize contact lens cases, better inform us on contact lens care solution (CLC) efficacy, and help us better understand the efficacy required of CLC products. To explore this gap in knowledge, we used Acanthamoeba ATCC 30461 and ATCC 50370 trophozoites to examine Acanthamoeba behavior during and after CLC disinfection. Amoebae were added to steril

APA, Harvard, Vancouver, ISO, and other styles

3

Suresh, Kumar, Singh Tanu, Ichhpujani Parul, and Vohra Sanchi. "Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost." romanian journal of ophthalmology 63, no. 3 (2019): 249–56. http://dx.doi.org/10.22336/rjo.2019.38.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Castro, Gerardo M. Ph.D, and Esmeraldo D. Jr. Ph.D Dimaculangan. "A Demand Strategy Fram ework for the Philippine Ophthalmology Market: A Mixed-Methods Study." ISIR Journal of Business and Management Studies (ISIRJBMS) 2, no. 1 (2025): 42–60. https://doi.org/10.5281/zenodo.14762204.

Full text

Abstract:

<em>This study examines the factors influencing the prescribing decisions of Filipino ophthalmologists </em><em>decisions using a mixed methods approach that combines conjoint analysis and phenomenology.  318 respondents participated in the conjoint analysis, and 7 took part in key informant interviews. Path-worth analysis was the statistical treatment utilized for conjoint analysis.   Respondents </em><em>favored generic medications with a strong corporate image and products with purite/polyquad preservatives.  Regular interactions with medical representatives, emphasizing

APA, Harvard, Vancouver, ISO, and other styles

5

Stahl, Erin, Dominique Bremond-Gignac, Theresa Landry, et al. "Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma." Journal of Ocular Pharmacology and Therapeutics 33, no. 5 (2017): 361–65. http://dx.doi.org/10.1089/jop.2016.0133.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ammar, David A., Robert J. Noecker, and Malik Y. Kahook. "Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells." Advances in Therapy 28, no. 6 (2011): 501–10. http://dx.doi.org/10.1007/s12325-011-0029-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nagstrup, Anne Hedengran. "The use of benzalkonium chloride in topical glaucoma treatment." Acta Ophthalmologica 101, S278 (2023): 3–21. http://dx.doi.org/10.1111/aos.15808.

Full text

Abstract:

AbstractENGLISH SUMMARY: Glaucoma is a leading cause of the global prevalence of irreversible blindness. The pathogenesis of glaucoma is not entirely known, but the major risk factors include advancing age, genetic predisposition, and increased intraocular pressure (IOP). The only evidence‐based treatment is a lowering of IOP through the use of eye drops, laser procedures, or surgical interventions. Although laser treatment is gaining recognition as a first‐choice treatment option, the most common approach for managing glaucoma is IOP‐lowering eye drops. A major challenge in the treatment is t

APA, Harvard, Vancouver, ISO, and other styles

8

Liang, Hong, Françoise Brignole-Baudouin, Luisa Riancho, and Christophe Baudouin. "Reduced in vivo Ocular Surface Toxicity with Polyquad-Preserved Travoprost versus Benzalkonium-Preserved Travoprost or Latanoprost Ophthalmic Solutions." Ophthalmic Research 48, no. 2 (2012): 89–101. http://dx.doi.org/10.1159/000335984.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ammar, David A., Robert J. Noecker, and Malik Y. Kahook. "Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells." Advances in Therapy 27, no. 11 (2010): 837–45. http://dx.doi.org/10.1007/s12325-010-0070-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rossi, Gemma Caterina Maria, Luigia Scudeller, Teresa Rolle, Gian Maria Pasinetti, and Paolo Emilio Bianchi. "From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability." Expert Opinion on Drug Safety 14, no. 5 (2015): 619–23. http://dx.doi.org/10.1517/14740338.2015.1017467.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Kemer, Özlem Evren, Priya Mekala, Bhoomi Dave, and Karanjit Singh Kooner. "Managing Ocular Surface Disease in Glaucoma Treatment: A Systematic Review." Bioengineering 11, no. 10 (2024): 1010. http://dx.doi.org/10.3390/bioengineering11101010.

Full text

Abstract:

Ocular surface disease (OSD) is a frequent disabling challenge among patients with glaucoma who use benzalkonium chloride (BAK)-containing topical glaucoma medications for prolonged periods. In this comprehensive review, we evaluated the prevalence of OSD and its management, focusing on both current and future alternatives. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were used to assess a) the impact of active ingredients and preservatives on the ocular surface and b) the efficacy of preservative-free (PF) alternatives and adjunctive therapies. BAK-cont

APA, Harvard, Vancouver, ISO, and other styles

12

Brignole-Baudouin, Françoise, Luisa Riancho, Hong Liang, Zaki Nakib, and Christophe Baudouin. "In Vitro Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination." Journal of Ocular Pharmacology and Therapeutics 27, no. 3 (2011): 273–80. http://dx.doi.org/10.1089/jop.2010.0111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

MacDougall, Nancy, Luigina Sorbara, Lyndon Jones, and Desmond Fonn. "THE CLINICAL PERFORMANCE OF A POLYQUAD-BASED CARE REGIMEN WITH A SILICONE-HYDROGEL MATERIAL USED ON A DAILY-WEAR BASIS." Optometry and Vision Science 78, SUPPLEMENT (2001): 309. http://dx.doi.org/10.1097/00006324-200112001-00513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gerlier, L., M. Lamotte, K. Lorenz, G. Berdeaux, Y. Verboven, and N. Pfeiffer. "PSS10 Economic Outcomes of Glaucoma Treatment With Prostaglandin Eye Drops Preserved With Polyquad® Instead of Benzalkonium Chloride in Germany." Value in Health 14, no. 7 (2011): A503. http://dx.doi.org/10.1016/j.jval.2011.08.1475.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Brignole-Baudouin, Françoise, Luisa Riancho, Hong Liang, and Christophe Baudouin. "ComparativeIn VitroToxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells." Current Eye Research 36, no. 11 (2011): 979–88. http://dx.doi.org/10.3109/02713683.2011.578781.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Gerlier, L., M. Lamotte, J. Caputo, and R. Tan. "PSS4 The Cost-Effectiveness of Travoprost Preserved With Polyquad® in Newly Treated Open-Angle Glaucoma Patients in 7 Asian Countries." Value in Health 15, no. 7 (2012): A643. http://dx.doi.org/10.1016/j.jval.2012.08.240.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Liang, Hong, Françoise Brignole-Baudouin, Aude Pauly, Luisa Riancho, and Christophe Baudouin. "Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study." Advances in Therapy 28, no. 4 (2011): 311–25. http://dx.doi.org/10.1007/s12325-011-0003-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lee, Hyun Joo, Roo Min Jun, Min Sun Cho та Kyu-Ryong Choi. "Comparison of the ocular surface changes following the use of two different prostaglandin F2αanalogues containing benzalkonium chloride or polyquad in rabbit eyes". Cutaneous and Ocular Toxicology 34, № 3 (2014): 195–202. http://dx.doi.org/10.3109/15569527.2014.944650.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hedengran, Anne, Josefine Freiberg, Pernille May Hansen, et al. "Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells." Journal of Optometry 17, no. 1 (2024): 100481. http://dx.doi.org/10.1016/j.optom.2023.100481.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Santodomingo-Rubido, Jacinto. "The comparative clinical performance of a new polyhexamethylene biguanide- vs a polyquad-based contact lens care regime with two silicone hydrogel contact lenses." Ophthalmic and Physiological Optics 27, no. 2 (2007): 168–73. http://dx.doi.org/10.1111/j.1475-1313.2006.00449.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

El Hajj Moussa, Wissam Georges, Rebecca Georges Farhat, Joseph Claud Nehme, et al. "Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients." Journal of Ophthalmology 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/1319628.

Full text

Abstract:

Aim. The purpose of this study is to evaluate and compare the efficacy of 4 prostaglandin analogues (PGAs) and to determine the incidence of ocular surface disease in newly diagnosed, primary open-angle glaucoma (POAG) patients started on one of those 4 PGAs: bimatoprost (benzalkonium chloride, BAK, 0.3 mg/mL), latanoprost (BAK 0.2 mg/mL), travoprost (polyquad), and tafluprost (BAK-free). Patients and Methods. In this single-center, open-label trial, 32 patients newly diagnosed with POAG were randomly started on one of the four PGAs. All patients underwent a complete ophthalmological exam at p

APA, Harvard, Vancouver, ISO, and other styles

22

GÖRGÜLÜ ŞAHİN, Burcu, Özcan OCAKOĞLU, İsmail SEÇKİN, Sibel DEMİRCİ DELİPINAR, Tuğba EKİZ YILMAZ, and Belisa KALECİ. "The Effects of Polyquad-Preserved Travoprost, Benzalkonium Chloride-Preserved Latanoprost, Purite-Preserved Brimonidine and Preservative-Free Tafluprost on Ocular Surface: A Rabbit Ocular Surface Study." Turkiye Klinikleri Journal of Ophthalmology 26, no. 3 (2017): 149–61. http://dx.doi.org/10.5336/ophthal.2016-52121.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Gerlier, L., M. Lamotte, G. Berdeaux, Y. Verboven, and N. Pfeiffer. "PSS4 Longer Term Patient Benefits of Polyquad® Preservative Instead of Benzalkonium Chloride in Prostaglandin Eye Drops: A Microsimulation Model in Ocular Hypertension and Open-Angle Glaucoma." Value in Health 14, no. 7 (2011): A502. http://dx.doi.org/10.1016/j.jval.2011.08.1469.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Tinoco Moran, Ivàn, Oscar Calderón Llosa, Margarita Olivares Gómez, Víctor Farinango Salazar, and Iván Chérrez Ojeda. "un Clinical case of anaphylaxis due to eye drops." Revista Alergia México 71, no. 1 (2024): 71. http://dx.doi.org/10.29262/ram.v71i1.1324.

Full text

Abstract:

Introduction: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological. Our objective is to report the case of a patient who presented anaphylaxis due to eye drops. Material and methods: A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0.4%, Propylene glycol 3 mg, polyquad 0.001%, presenting at 15 minutes an episode of anaphylaxis

APA, Harvard, Vancouver, ISO, and other styles

25

Melikhov, Dmitri. "Exotic polyquark states and their properties in QCD." EPJ Web of Conferences 158 (2017): 01006. http://dx.doi.org/10.1051/epjconf/201715801006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Mason, J., W. Nailon, A. Perelli, S. Andiappa, and M. Davies. "EP-2069 Improved dose calculation on CBCT using polyenergetic quantitative (Polyquant) reconstruction." Radiotherapy and Oncology 133 (April 2019): S1140—S1141. http://dx.doi.org/10.1016/s0167-8140(19)32489-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Willcox, Mark DP, Percy Lazon de la Jara, Daniel Tilia, and Hua Zhu. "Effect of a multipurpose disinfecting solution containing Polyquat and Alexidine on contamination of contact lens cases during use." Contact Lens and Anterior Eye 34 (December 2011): S10. http://dx.doi.org/10.1016/s1367-0484(11)60049-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Mason, Jonathan H., Alessandro Perelli, William H. Nailon, and Mike E. Davies. "Polyquant CT: direct electron and mass density reconstruction from a single polyenergetic source." Physics in Medicine & Biology 62, no. 22 (2017): 8739–62. http://dx.doi.org/10.1088/1361-6560/aa9162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Liu, Zhanpeng, Yuanbin Lin, Xiaohong Wen, and Qiong Su. "Preparation and electrorheological properties of polyquin(2,3-b)acridine-12,14(5,7)dione-based suspensions." Colloids and Surfaces A: Physicochemical and Engineering Aspects 264, no. 1-3 (2005): 55–60. http://dx.doi.org/10.1016/j.colsurfa.2005.05.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Hong, Cheng Hai, and Hyoung Jin Choi. "Comment on “Preparation and electrorheological properties of polyquin(2,3-b)acridine-12,14(5,7)dione-based suspensions”." Colloids and Surfaces A: Physicochemical and Engineering Aspects 295, no. 1-3 (2007): 288–90. http://dx.doi.org/10.1016/j.colsurfa.2006.08.027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Gonsior, Nina, Sarah Schmitz, and Helmut Ritter. "Thermal Sensitivity of tert-Butyloxycarbonylmethyl-Modified Polyquats in Condensed Phase and Solubility Properties of Copolymers with N-Isopropylacrylamide." Macromolecular Chemistry and Physics 211, no. 15 (2010): 1695–700. http://dx.doi.org/10.1002/macp.201000077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Alnoor, Umalbaninn, Simone Ahrensberg, Josefine Freiberg, Miriam Kolko, Anne Nagstrup, and Steffen Heegaard. "Artificial tears, preservatives, so what?" Acta Ophthalmologica 102, S279 (2024). http://dx.doi.org/10.1111/aos.16012.

Full text

Abstract:

Aims/Purpose: To investigate the cell survival of human conjunctival goblet cells (CGs) when incubated with preserved and preservative‐free (PF) artificial tears (AT) used against dry eye disease (DED). The following ATs were tested: 0.011% benzalkonium chloride (BAK)‐preserved Viskøse® Øjendråber, 0.006% BAK‐preserved Oftagel®, 0.005% BAK‐preserved Oculac®, 0.001% PolyQuad™‐preserved Systane® Ultra, 0.01% Cetrimide‐preserved Artelac®, and PF ATs: Systane® Ultra, Oculac®, Oftagel®, and Thealoz® Duo.Methods: Primary cultures of human conjunctival CGs were cultivated from donor conjunctiva. Afte

APA, Harvard, Vancouver, ISO, and other styles

33

Alnoor, Umalbaninn, Simone Ahrensberg, Steffen Heegaard, and Miriam Kolko. "The physiochemical properties of artificial tears and their impact on human cultured conjunctival goblet cells." Acta Ophthalmologica 103, S284 (2025). https://doi.org/10.1111/aos.17216.

Full text

Abstract:

Aims/Purpose: To investigate the cell survival and mucin release (Muc5AC) of human conjunctival goblet cells (GCs) when incubated with preserved and preservative‐free (PF) artificial tears (AT), and to compare the physicochemical properties of these ATs. Ten different ATs were examined, five containing preservatives (benzalkonium chloride (BAK), PolyQuad, and cetrimide) and five preservative‐free.Methods: Primary cultures of human conjunctival GCs were cultivated from donor conjunctiva. After incubation with ATs diluted 1: 7 or 1: 3.5 in culture media for 2 hours, GC survival was analysed usin

APA, Harvard, Vancouver, ISO, and other styles

34

Muz, Omer Ersin, Kenan Dagdelen, Tuncay Pirdal, and Mete Guler. "Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension." International Ophthalmology, July 14, 2021. http://dx.doi.org/10.1007/s10792-021-01947-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Nagstrup, Anne, Josefine Freiberg, Pernille May Hansen, et al. "Comparing the effect of benzalkonium chloride‐preserved, polyquad‐preserved, and preservative‐free prostaglandin analogue eye drops on cultured human conjunctival goblet cells." Acta Ophthalmologica 102, S279 (2024). http://dx.doi.org/10.1111/aos.16182.

Full text

Abstract:

Aims/Purpose: To investigate the effect of benzalkonium chloride (BAK)‐preserved latanoprost and bimatoprost, polyquad (PQ)‐preserved travoprost, and preservative‐free (PF) latanoprost and tafluprost, all prostaglandin analogues (PGAs), on human conjunctival goblet cell (GC) survival. Furthermore, to investigate the effect of BAK‐preserved and PF latanoprost on the cytokine secretion from GC.Methods: Primary human conjunctival GCs were cultivated from donor tissue. Lactate dehydrogenase (LDH) and tetrazolium dye colorimetric (MTT) assays were used for the assessment of GC survival. A cytometri

APA, Harvard, Vancouver, ISO, and other styles

36

Ahrensberg, Simone, Jens Rovelt Andreasen, and Miriam Kolko. "The use of artificial tears among the danish population: Epidemiological observations." Acta Ophthalmologica 102, S279 (2024). http://dx.doi.org/10.1111/aos.15998.

Full text

Abstract:

Aims/Purpose: To investigate the use of artificial tears (AT), identify which eye diseases are most prevalent among the users, determine which products are preferred by the population, and analyse their preservative content.Methods: Data originate from the FOREVER questionnaire. Respondents are customers from Synoptik A/S aged from 18 years and of both genders, and have given written consent for the use of their data. All 48 AT in the questionnaire appear in The Nordic Guidelines Dry Eye Disease 2022. T‐test and chi2 were performed to examine significant differences in the data.Results: 41.723

APA, Harvard, Vancouver, ISO, and other styles

37

Melikhov, Dmitri, and Berthold Stech. "Fall-apart decays of polyquark hadrons." Physical Review D 74, no. 3 (2006). http://dx.doi.org/10.1103/physrevd.74.034022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

"Polyquart Ecoclean: “green” convenience for hard surface cleaners." Focus on Surfactants 2009, no. 12 (2009): 5. http://dx.doi.org/10.1016/s1351-4210(09)70376-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

JONNA, SANKARAIAH, HANIMI REDDY BAPATU, PRAVEEN SUBBAPPA, and KALIYAPERUMAL SARAVANAN. "A QBD WITH THE FRACTIONAL FACTORIAL DESIGN WAS USED TO MATCH THE SIMILARITY BETWEEN RANOLAZINE EXTENDED-RELEASE TABLETS 500 MG AND 1000 MG." International Journal of Applied Pharmaceutics, March 7, 2023, 98–105. http://dx.doi.org/10.22159/ijap.2023v15i2.47241.

Full text

Abstract:

Objective: Formulation and development of Ranolazine extended-release Tablets 500 mg and 1000 mg by using QBD with Fractional factorial design to match the similarity with Branded formulation (RANEXA®). Methods: Ranolazine extended-release tablets were developed by using various polymers, Polyquid PA100 and ETHOCEL TMstandard 7 premium and Hypromellose with a wet granulation process. QBD (Quality by Design) approach was used to identify the formulation and process variables that may affect the CQAs (critical quality attributes). Excipient compatibility studies were conducted to identify the in

APA, Harvard, Vancouver, ISO, and other styles

40

Koller, Michael, Antonio Ernstberger, Florian Zeman, Julika Loss, and Michael Nerlich. "Outcome after polytrauma in a certified trauma network: comparing standard vs. maximum care facilities concept of the study and study protocol (POLYQUALY)." BMC Health Services Research 16, no. 1 (2016). http://dx.doi.org/10.1186/s12913-016-1468-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!